RELA, RELA proto-oncogene, NF-kB subunit, 5970

N. diseases: 483; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 Biomarker phenotype BEFREE In addition, expression of phospho-ERK (p-ERK), NF-κB p65 (Ser536), and tumor progression-associated proteins, such as matrix metallopeptidase 9 (MMP-9), vascular endothelial growth factor (VEGF), X-linked inhibitor of apoptosis protein (XIAP), and CyclinD1 were all significantly decreased by magnolol. 31714653 2020
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 GeneticVariation phenotype BEFREE In addition, we confirmed that autophagy was related to NF-κB inhibition in cancer progression, especially with the nuclear translocation of p65. 30955240 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 Biomarker phenotype BEFREE Cell viability, DNA damage and the mRNA expression of the CDC25C (cell division cycle 25C), CDKN1A (cyclin dependent kinase inhibitor 1A) and CHEK1 (checkpoint kinase 1), SQSTM1 (sequestosome 1) and ULK1 (unc-51 like autophagy activating kinase 1), RELA (RELA proto-oncogene, NF-κB subunit) and TP53BP1 (tumor protein p53 binding protein 1) genes important in cell cycle regulation, autophagy and cancer progression were investigated. 31284710 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 Biomarker phenotype BEFREE The results indicated regorafenib significantly reduced tumor growth and expression of phosphorylated ERK, NF-κB p65 (Ser536), phosphorylated AKT, and tumor progression-associated proteins. 29535278 2018
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 AlteredExpression phenotype BEFREE Ectopic expression of RPA2 inhibited the formation of the menin-NK-κB p65 complex and repressed the inhibitory effect of menin on expression of NF-κB-regulated genes that contribute to tumor progression. 28007956 2017
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 Biomarker phenotype BEFREE Multivariate analysis using the Cox regression model confirmed that co-expression of nuclear β-arrestin1 and p65 was an independent prognostic factor for tumor progression (p = 0.008). 25820700 2015
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.070 Biomarker phenotype BEFREE HBsAg inhibited the translocation of JTB to the mitochondria and decreased the phosphorylation of p65 through the interaction with JTB, After JTB knockdown, HBsAg exhibited a stronger potential to promote tumor progression. 22615844 2012